Navigation Links
U.S. Patent Infringement Lawsuit Filed by Aperio Technologies, Inc.
Date:6/23/2009

HAMAMATSU, Japan, June 23 /PRNewswire/ -- A U.S. patent infringement lawsuit was filed on June 10, 2009, against Hamamatsu Photonics K.K., Hamamatsu Corporation, and Olympus America, Inc. The lawsuit, brought by Aperio Technologies, Inc. in the U.S. District Court for the District of Delaware, accuses products incorporating Hamamatsu Photonics K.K. NanoZoomer(R) technology of infringing Aperio U.S. Patent Nos. 6,917,696; 7,457,446; and 7,518,652.

The lawsuit follows a series of letters issued by Aperio in which Aperio alleged infringement. Hamamatsu Photonics K.K. has carefully analyzed the asserted claims and concluded that its NanoZoomer(R) product is not covered by any of the patents that Aperio has identified. Hamamatsu Photonics K.K. responded to each letter from Aperio by pointing out its belief that the asserted patents did not cover the Hamamatsu Photonics K.K. NanoZoomer(R) technology. Aperio has not responded to any of the requests by Hamamatsu Photonics K.K. for further details and information. Instead, Aperio filed the current lawsuit in U.S. District Court, without any reply to the non-infringement positions brought to its attention by Hamamatsu Photonics K.K.

Hamamatsu Photonics K.K. respects the valid intellectual property rights of other companies, and has an excellent reputation world-wide for dealing fairly with its competition. Hamamatsu Photonics K.K. believes that its NanoZoomer(R) technology is not covered by any valid claims of the patents asserted by Aperio in the pending litigation. Hamamatsu Photonics K.K. will vigorously defend itself and fully expects to achieve a favorable outcome before the U.S. District Court for the District of Delaware.

About Hamamatsu Corporation

Hamamatsu Corporation is the North American subsidiary of Hamamatsu Photonics K.K. (Japan), a leading manufacturer of devices for the generation and measurement of infrared, visible, and ultraviolet light. These devices include photodiodes, photomultiplier tubes, scientific light sources, infrared detectors, photoconductive cells, and image sensors. The parent company is dedicated to the advancement of photonics through extensive research. This corporate philosophy results in state-of-the-art products which are used throughout the world in scientific, industrial, and commercial applications.


'/>"/>
SOURCE Hamamatsu Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
2. Spectranetics to Appeal Decision in Patent Litigation
3. Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs
4. Actavis Confirms its Patent Challenge of Kings Avinza(R)
5. PartsSource Awarded US Patent for PartsFinder(TM) Application
6. Barr Confirms Patent Challenge of UROXATRAL(R)
7. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
8. VNUS Medicals Patent Lawsuit Against Laser Competitors to Proceed to Trial
9. Aida Granted Additional Anti-Cancer Patent
10. China Medicines ADTZ Project Has Been Selected as One of Six Patent Commercialization Projects in Guangdong Province
11. Wiley X Eyewear(R) Announces Successful Resolution of Patent Infringement Litigation Against PanOptx(R), Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy ... the preferred physical therapy provider for Derby City CrossFit, effective immediately. , In ... as quickly and effectively as possible, ProRehab’s sports physical therapists will work with ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... contracted partners to help with process innovation in drug formulation and manufacturing. ... along with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Conference at the InterContinental Hotel in Boston, ... Biomet will present at 11:20 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: